These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 30855675)

  • 41. Validation of methylation-based forensic age estimation in time-series bloodstains on FTA cards and gauze at room temperature conditions.
    Peng F; Feng L; Chen J; Wang L; Li P; Ji A; Zeng C; Liu F; Li C
    Forensic Sci Int Genet; 2019 May; 40():168-174. PubMed ID: 30878720
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cypiripi: exact genotyping of CYP2D6 using high-throughput sequencing data.
    Numanagić I; Malikić S; Pratt VM; Skaar TC; Flockhart DA; Sahinalp SC
    Bioinformatics; 2015 Jun; 31(12):i27-34. PubMed ID: 26072492
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sequencing CYP2D6 for the detection of poor-metabolizers in post-mortem blood samples with tramadol.
    Fonseca S; Amorim A; Costa HA; Franco J; Porto MJ; Santos JC; Dias M
    Forensic Sci Int; 2016 Aug; 265():153-9. PubMed ID: 26926096
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation of CYP2D6 genotype with perhexiline phenotypic metabolizer status.
    Barclay ML; Sawyers SM; Begg EJ; Zhang M; Roberts RL; Kennedy MA; Elliott JM
    Pharmacogenetics; 2003 Oct; 13(10):627-32. PubMed ID: 14515061
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CYP2D6 copy number distribution in the US population.
    Beoris M; Amos Wilson J; Garces JA; Lukowiak AA
    Pharmacogenet Genomics; 2016 Feb; 26(2):96-9. PubMed ID: 26551314
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A rapid and simple CYP2D6 genotyping assay--case study with the analgetic tramadol.
    Borlak J; Hermann R; Erb K; Thum T
    Metabolism; 2003 Nov; 52(11):1439-43. PubMed ID: 14624403
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Isolation, sequence and genotyping of the drug metabolizer CYP2D6 gene in the Colombian population.
    Isaza CA; Henao J; López AM; Cacabelos R
    Methods Find Exp Clin Pharmacol; 2000 Nov; 22(9):695-705. PubMed ID: 11294012
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of cytochrome P450 2D6 alleles using the Invader system.
    Nevilie M; Selzer R; Aizenstein B; Maguire M; Hogan K; Walton R; Welsh K; Neri B; de Arruda M
    Biotechniques; 2002 Jun; Suppl():34-8, 40-3. PubMed ID: 12083395
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.
    Scordo MG; Caputi AP; D'Arrigo C; Fava G; Spina E
    Pharmacol Res; 2004 Aug; 50(2):195-200. PubMed ID: 15177309
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Frequencies of three CYP2D6 nonfunctional alleles (CYP2D6*3, *4, and *6) within an Iranian population (Mazandaran).
    Hashemi-Soteh SM; Sarzare F; Merat F; Salehifar E; Shiran MR
    Genet Test Mol Biomarkers; 2011 Nov; 15(11):821-5. PubMed ID: 21631295
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyrius: accurate CYP2D6 genotyping using whole-genome sequencing data.
    Chen X; Shen F; Gonzaludo N; Malhotra A; Rogert C; Taft RJ; Bentley DR; Eberle MA
    Pharmacogenomics J; 2021 Apr; 21(2):251-261. PubMed ID: 33462347
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genotyping DNA isolated from UV irradiated human bloodstains using whole genome amplification.
    Uchigasaki S; Tie J; Sobashima E; Shimada N
    Mol Biol Rep; 2018 Oct; 45(5):925-929. PubMed ID: 29982892
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential quantification of CYP2D6 gene copy number by four different quantitative real-time PCR assays.
    Ramamoorthy A; Flockhart DA; Hosono N; Kubo M; Nakamura Y; Skaar TC
    Pharmacogenet Genomics; 2010 Jul; 20(7):451-4. PubMed ID: 20421845
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of CYP2D6 genotype on the disposition of the enantiomers of venlafaxine and its major metabolites in postmortem femoral blood.
    Kingbäck M; Karlsson L; Zackrisson AL; Carlsson B; Josefsson M; Bengtsson F; Ahlner J; Kugelberg FC
    Forensic Sci Int; 2012 Jan; 214(1-3):124-34. PubMed ID: 21840145
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genotyping CYP2D6 by three different methods: advantages and disadvantages.
    Ribeiro C; Martins P; Grazina M
    Drug Metab Pers Ther; 2017 Mar; 32(1):33-37. PubMed ID: 28170339
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection and characterization of the CYP2D6*9x2 gene duplication in two Spanish populations: resolution of AmpliChip CYP450 test no-calls.
    Gaedigk A; Hernandez J; García-Solaesa V; Sánchez S; Isidoro-García M
    Pharmacogenomics; 2011 Nov; 12(11):1617-22. PubMed ID: 22044417
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of Reference Materials for Genetic Testing of CYP2D6 Alleles: A GeT-RM Collaborative Project.
    Gaedigk A; Turner A; Everts RE; Scott SA; Aggarwal P; Broeckel U; McMillin GA; Melis R; Boone EC; Pratt VM; Kalman LV
    J Mol Diagn; 2019 Nov; 21(6):1034-1052. PubMed ID: 31401124
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Validation of Marek's disease diagnosis and monitoring of Marek's disease vaccines from samples collected in FTA cards.
    Cortes AL; Montiel ER; Gimeno IM
    Avian Dis; 2009 Dec; 53(4):510-6. PubMed ID: 20095150
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enantioselective analysis of citalopram and escitalopram in postmortem blood together with genotyping for CYP2D6 and CYP2C19.
    Carlsson B; Holmgren A; Ahlner J; Bengtsson F
    J Anal Toxicol; 2009 Mar; 33(2):65-76. PubMed ID: 19239731
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rapid and reliable genotyping procedure for detection of alleles with mutations, deletion, or/and duplication of the CYP2D6 gene.
    Arneth B; Shams M; Hiemke C; Härtter S
    Clin Biochem; 2009 Aug; 42(12):1282-90. PubMed ID: 19393232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.